Antisense Oligonucleotides and RNA Interference - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 374

[76] Sproat BS, Lamond AI, Beijer B, Neuner P, Ryder U. Highly efficient chemical synthesis
of 2- O -methyloligoribonucleotides and tetrabiotinylated derivatives; novel probes that
are resistant to degradation by RNA or DNA specific nucleases. Nucleic Acids Res 1989;
17:3373-86.
[77] Morvan F, Rayner B, Imbach JL. Alpha-oligonucleotides: a unique class of modified chi-
meric nucleic acids. Anticancer Drug Des 1991;6:521-9.
[78] Gagnor C, Rayner B, Leonetti JP, Imbach JL, Lebleu B. Alpha-DNA.IX: parallel annealing
of alpha-anomeric oligodeoxyribonucleotides to natural mRNA is required for interference
in RNase H mediated hydrolysis and reverse transcription. Nucleic Acids Res 1989;17:
5107-14.
[79] Maher LJ III, Wold B, Dervan PB. Inhibition of DNA binding proteins by oligonucle-
otide-directed triple helix formation. Science 1989;245:725-30.
[80] Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agents-is the bullet really
magical? Science 1993;261:1004-12.
[81] Mirabelli CK, Bennett CF, Anderson K, Crooke ST. In vitro and in vivo pharmacologic
activities of antisense oligonucleotides. Anticancer Drug Des 1991;6:647-61.
[82] Baker BF, Monia BP. Novel mechanisms for antisense-mediated regulation of gene
expression. Biochim Biophys Acta 1999;1489:3-18.
[83] Summerton J. Morpholino antisense oligomers: the case for an RNase H independent
structural type. Biochim Biophys Acta 1999;1489:141-58.
[84] Kulka M, Smith CC, Aurelian L, Fishelevich R, Meade K, Miller P, et al. Site specificity
of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the
acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4. Proc
Natl Acad Sci USA 1989;86:6868-72.
[85] McManaway ME, Neckers LM, Loke SL, al-Nasser AA, Redner RL, Shiramizu BT,
et al. Tumor-specific inhibition of lymphoma growth by an antisense oligonucleotide.
Lancet 1990;335:808811.
[86] Sierakowska H, Sambade MJ, Agrawal S, Kole R. Repair of thalassemic human b-globin
mRNA in mammalian cells by antisense oligonucleotides. Proc NatlAcad Sci USA 1996;93:
12840-4.
[87] Dominski Z, Kole R. Restoration of correct splicing in thalassemic pre-mRNA by anti-
sense oligonucleotides. Proc Natl Acad Sci USA 1993;90:8673-7.
[88] Knudsen H, Nielsen PE. Antisense properties of duplex- and triplex-forming PNAs.
Nucleic Acids Res 1996;24:494-500.
[89] Gambacorti-Passerini C, Mologni L, Bertazzoli C, Coutre P, Marchesi E, Grignani F,
et al. In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/
retinoic acid receptor alpha and anti-PML peptide nucleic acid. Blood 1996;88:1411-17.
[90] Agrawal S, Goodchild J, Civeira MP, Thornton AH, Sarin PS, Zamecnik PC.
Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human
immunodeficiency virus. Proc Natl Acad Sci USA 1988;85:7079-83.
[91] Lemaitre M, Bayard B, Lebleu B. Specific antiviral activity of a poly(L-lysine)-
conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis
virus N protein mRNA initiation site. Proc Natl Acad Sci USA 1987;84:648-52.
[92] Chiang MY, Chan H, Zounes MA, Freier SM, Lima WF, Bennett CF. Antisense oligo-
nucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mecha-
nisms. J Biol Chem 1991;266:18162-71.
[93] Lebleu B, Moulton HM, Abes R, Ivanova GD, Abes S, Stein DA, et al. Cell penetrat-
ing peptide conjugates of steric block oligonucleotides. Adv Drug Deliv Rev 2008;60:
517-29.